Peter Diamandis
- Known for
- XPRIZE Foundation, Singularity University
- Born in
- Bronx, New York, USA
- Education
- MD, Harvard Medical School
Peter Diamandis is an American engineer, physician, and serial entrepreneur defined by his relentless optimism regarding the future. He is the driving force behind the XPRIZE Foundation and Singularity University, championing the idea that exponential technologies can solve humanity's grand challenges.
His worldview centers on Abundance, believing that technology and innovation are poised to dramatically raise global standards of living for everyone.
Signature Positions
Diamandis's career is characterized by a focus on incentivizing monumental achievements through prize competitions:
- XPRIZE Foundation: Founded to foster radical innovation through large-scale incentive prizes, notably funding the first private manned spaceflight with the Ansari XPRIZE.
- Space Exploration: Co-founded numerous space ventures including Space Adventures and Planetary Resources, aiming to democratize access to and utilization of space.
- Longevity: Deeply committed to extending healthy human lifespan, co-founding Human Longevity Inc. (HLI) and Celularity, and launching the $101 million XPRIZE Healthspan.
- Exponential Technologies: Advocates for leveraging converging technologies in books like Abundance and Bold to create massive positive global impact.
Diamandis is positioned as a leading futurist and an architect of the 'tech for good' movement. He is known for fostering collaborations with high-profile individuals, including Elon Musk and Ray Kurzweil, who serve on the XPRIZE Foundation board.
His work in Artificial Intelligence and Longevity places him at the forefront of debates concerning the ethical and societal implications of rapid technological acceleration.
Notable Tensions
Diamandis's high-profile career has faced notable controversy:
- COVID-19 Event: In 2021, he hosted a high-cost, mostly maskless gathering in Santa Monica that became a superspreading event, leading to widespread media scrutiny.
- Alternative Treatments: Following the event, a webinar connected to attendees allegedly promoted unproven or 'fraudulent' COVID-19 treatments, drawing sharp criticism regarding scientific rigor.